Cargando…

TREM2 is associated with increased risk for Alzheimer’s disease in African Americans

BACKGROUND: TREM2 encodes for triggering receptor expressed on myeloid cells 2 and has rare, coding variants that associate with risk for late-onset Alzheimer’s disease (LOAD) in Caucasians of European and North-American origin. This study evaluated the role of TREM2 in LOAD risk in African-American...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Sheng Chih, Carrasquillo, Minerva M, Benitez, Bruno A, Skorupa, Tara, Carrell, David, Patel, Dwani, Lincoln, Sarah, Krishnan, Siddharth, Kachadoorian, Michaela, Reitz, Christiane, Mayeux, Richard, Wingo, Thomas S, Lah, James J, Levey, Allan I, Murrell, Jill, Hendrie, Hugh, Foroud, Tatiana, Graff-Radford, Neill R, Goate, Alison M, Cruchaga, Carlos, Ertekin-Taner, Nilüfer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426167/ https://www.ncbi.nlm.nih.gov/pubmed/25886450 http://dx.doi.org/10.1186/s13024-015-0016-9

Ejemplares similares

Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer’s disease brains
por: Ma, Li, et al.
Publicado: (2016)

ABCA7 loss-of-function variants, expression, and neurologic disease risk
por: Allen, Mariet, et al.
Publicado: (2017)

Plasma Biomarkers of Alzheimer’s Disease in African Americans
por: Deniz, Kaancan, et al.
Publicado: (2021)

Transcript levels in plasma contribute substantial predictive value as potential Alzheimer's disease biomarkers in African Americans
por: Reddy, Joseph S., et al.
Publicado: (2022)

Comparative evaluation for the globin gene depletion methods for mRNA sequencing using the whole blood-derived total RNAs
por: Jang, Jin Sung, et al.
Publicado: (2020)

Late-onset Alzheimer disease risk variants mark brain regulatory loci
por: Allen, Mariet, et al.
Publicado: (2015)

TREM2 p.R47H substitution is not associated with dementia with Lewy bodies
por: Walton, Ronald L., et al.
Publicado: (2016)

African American exome sequencing identifies potential risk variants at Alzheimer disease loci
por: N'Songo, Aurelie, et al.
Publicado: (2017)

Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease
por: Ertekin-Taner, Nilüfer
Publicado: (2011)

Genetics of Alzheimer disease in the pre- and post-GWAS era
por: Ertekin-Taner, Nilüfer
Publicado: (2010)

Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels
por: Allen, Mariet, et al.
Publicado: (2014)

TMEM106B haplotypes have distinct gene expression patterns in aged brain
por: Ren, Yingxue, et al.
Publicado: (2018)

Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease
por: Li, Hong‐Dong, et al.
Publicado: (2021)

Correction: Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012)

Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
por: Cruchaga, Carlos, et al.
Publicado: (2012)

TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers
por: Del-Aguila, Jorge L., et al.
Publicado: (2019)

Ethnoracial differences in Alzheimer’s disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort
por: Santos, Octavio A., et al.
Publicado: (2019)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease
por: Rayaprolu, Sruti, et al.
Publicado: (2013)

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer’s disease
por: Medway, Christopher W, et al.
Publicado: (2014)

Latent trait modeling of tau neuropathology in progressive supranuclear palsy
por: Kouri, Naomi, et al.
Publicado: (2021)

Clinical Deep Phenotyping of ABCA7 Mutation Carriers
por: Campbell, Alana S., et al.
Publicado: (2022)

The SERPINA5 coding variant E228Q does not contribute to clinicopathologic characteristics in Alzheimer’s disease: A cross-sectional study
por: Matchett, Billie J., et al.
Publicado: (2023)

Fine particulate air pollution and neuropathology markers of Alzheimer’s disease in donors with and without APOE ε4 alleles – results from an autopsy cohort
por: Christensen, Grace M., et al.
Publicado: (2023)

Brain Expression Genome-Wide Association Study (eGWAS) Identifies Human Disease-Associated Variants
por: Zou, Fanggeng, et al.
Publicado: (2012)

Alternative Approaches in Gene Discovery and Characterization in Alzheimer’s Disease
por: Ertekin-Taner, Nilüfer, et al.
Publicado: (2013)

Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue
por: Ma, Yiyi, et al.
Publicado: (2021)

Identification of missing variants by combining multiple analytic pipelines
por: Ren, Yingxue, et al.
Publicado: (2018)

LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)
por: Lincoln, Sarah, et al.
Publicado: (2013)

Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy
por: Strickland, Samantha L., et al.
Publicado: (2020)

Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies
por: Wickland, Daniel P., et al.
Publicado: (2021)

MAPT haplotype–stratified GWAS reveals differential association for AD risk variants
por: Strickland, Samantha L., et al.
Publicado: (2020)

Function of TREM1 and TREM2 in Liver-Related Diseases
por: Sun, Huifang, et al.
Publicado: (2020)

Differential DNA Methylation in the Brain as Potential Mediator of the Association between Traffic-related PM(2.5) and Neuropathology Markers of Alzheimer’s Disease
por: Li, Zhenjiang, et al.
Publicado: (2023)

Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions
por: Wang, Xue, et al.
Publicado: (2022)

Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease
por: Hanna Al-Shaikh, Fadi S., et al.
Publicado: (2019)

Genome-wide analysis identifies a novel LINC-PINT splice variant associated with vascular amyloid pathology in Alzheimer’s disease
por: Reddy, Joseph S., et al.
Publicado: (2021)

ABI3 and PLCG2 missense variants as risk factors for neurodegenerative diseases in Caucasians and African Americans
por: Conway, Olivia J, et al.
Publicado: (2018)

Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms
por: Kober, Daniel L, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2i6s5valjlknoju3i4pelsfbhk